Cargando…
Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer
In current practice, prostate cancer staging alone is not sufficient to adequately assess the patient’s prognosis and plan the management strategies. Multiple clinicopathological parameters and risk tools for prostate cancer have been developed over the past decades to better characterize the diseas...
Autores principales: | Saoud, Ragheed, Heidar, Nassib Abou, Cimadamore, Alessia, Paner, Gladell P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564222/ https://www.ncbi.nlm.nih.gov/pubmed/32957584 http://dx.doi.org/10.3390/cells9092116 |
Ejemplares similares
-
Long term renal function following selective angioembolization for iatrogenic vascular lesions after partial nephrectomy: A matched case-control study
por: Saoud, Ragheed, et al.
Publicado: (2021) -
Prostate cancer: a presentation of clinicopathologic prognosticators among Filipino and American men at radical prostatectomy
por: Grageda, Mayen T, et al.
Publicado: (2021) -
Acquired Bilateral Seminal Vesicle Cysts: A Rare Manifestation of Prostate Cancer
por: Abou Heidar, Nassib, et al.
Publicado: (2019) -
Relative prognostic value of TNM7 vs TNM6 in staging oesophageal cancer
por: Reid, T D, et al.
Publicado: (2011) -
Novel staging for gastric neuroendocrine neoplasms by incorporating the WHO grading into the TNM staging system
por: Zhang, Rihong, et al.
Publicado: (2022)